Risk factors for systemic Candida infections in pediatric small bowel transplant recipients

Pediatric Infectious Disease Journal

Volumn 31, Issue 2, 2012, Pages 120-123

  Florescu, Diana F ^a   Qiu, Fang ^b   Mercer, David F ^b   Langnas, Alan N ^b   Shafer, Laura R ^a   Kalil, Andre C ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Candida; Pediatric; Risk factors; Small bowel; Transplant

Indexed keywords

ADOLESCENT; ANTIBIOTIC THERAPY; ARTICLE; CANDIDIASIS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FUNGEMIA; HUMAN; INFANT; INFECTION RISK; INTESTINE TRANSPLANTATION; MALE; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD; SMALL INTESTINE; TOTAL PARENTERAL NUTRITION;

ADOLESCENT; ANTI-BACTERIAL AGENTS; CANDIDIASIS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; INFANT; INTESTINAL DISEASES; INTESTINE, SMALL; MALE; ORGAN TRANSPLANTATION; PARENTERAL NUTRITION, TOTAL; RETROSPECTIVE STUDIES; RISK FACTORS; TRANSPLANTATION;

EID: 84858152138     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e31823a66d5     Document Type: Article

References (20)

1. Singh N. Antifungal prophylaxis for solid organ transplant recipients: seeking clarity amidst controversy. Clin Infect Dis. 2000;31:545-553. (Pubitemid 32289589)
2. Mahieu LM, Van Gasse N, Wildemeersch D, et al. Number of sites of perinatal Candida colonization and neutropenia are associated with nosocomial candidemia in the neonatal intensive care unit patient. Pediatr Crit Care Med. 2010;11:240 -245.
3. Anunnatsiri S, Chetchotisakd P, Mootsikapun P. Fungemia in non-HIVinfected patients: a five-year review. Int J Infect Dis. 2009;13:90 -96.
4. van Asbeck EC, Huang YC, Markham AN, et al. Candida parapsilosis fungemia in neonates: genotyping results suggest healthcare workers hands as source, and review of published studies. Mycopathologia. 2007;164:287-293. (Pubitemid 47622127)
5. Horn DL, Neofytos D, Anaissie EJ, et al. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry. Clin Infect Dis. 2009;48:1695-1703.
6. Florescu DF, Islam KM, Grant W, et al. Incidence and outcome of fungal infections in pediatric small bowel transplant recipients. Transpl Infect Dis. 2010;12:497-504.
7. Ascioglu S, Rex JH, de Pauw B, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis. 2002;34:7-14. (Pubitemid 33152659)
8. Firth D. Bias reduction of maximum likelihood estimates. Biometrika. 1993;80:27-38.
9. Heinze G, Puhr R. Bias-reduced and separation-proof conditional logistic regression with small or sparse data sets. Stat Med. 2010;29:770-777.
10. Verma A, Wade JJ, Cheeseman P, et al. Risk factors for fungal infection in paediatric liver transplant recipients. Pediatr Transplant. 2005;9:220-225. (Pubitemid 40476852)
11. Marin VB, Rebollo MG, Castillo-Duran CD, et al. Controlled study of early postoperative parenteral nutrition in children. J Pediatr Surg. 1999;34:1330-1335. (Pubitemid 29439418)
12. Gupte GL, Beath SV. Update on intestinal rehabilitation after intestinal transplantation. Curr Opin Organ Transplant. 2009;14:267-273.
13. Singh N, Paterson DL, Gayowski T, et al. Preemptive prophylaxis with a lipid preparation of amphotericin B for invasive fungal infections in liver transplant recipients requiring renal replacement therapy. Transplantation. 2001;71:910-913. (Pubitemid 32417353)
14. Lumbreras C, Cuervas-Mons V, Jara P, et al. Randomized trial of fluconazole versus nystatin for the prophylaxis of Candida infection following liver transplantation. J Infect Dis. 1996;174:583-588. (Pubitemid 26299693)
15. Winston DJ, Pakrasi A, Busuttil RW. Prophylactic fluconazole in liver transplant recipients. A randomized, double-blind, placebo-controlled trial. Ann Intern Med. 1999;131:729-737. (Pubitemid 29531981)
16. Sharpe MD, Ghent C, Grant D, et al. Efficacy and safety of itraconazole prophylaxis for fungal infections after orthotopic liver transplantation: a prospective, randomized, double-blind study. Transplantation. 2003;76:977-983. (Pubitemid 37186031)
17. Winston DJ, Busuttil RW. Randomized controlled trial of oral itraconazole solution versus intravenous/oral fluconazole for prevention of fungal infections in liver transplant recipients. Transplantation. 2002;74:688-695.
18. Hellinger WC, Yao JD, Alvarez S, et al. A randomized, prospective, double-blinded evaluation of selective bowel decontamination in liver transplantation. Transplantation. 2002;73:1904-1909. (Pubitemid 34700997)
19. Hjortrup A, Rasmussen A, Hansen BA, et al. Early bacterial and fungal infections in liver transplantation after oral selective bowel decontamination. Transplant Proc. 1997;29:3106-3110. (Pubitemid 27484273)
20. Arnow PM, Carandang GC, Zabner R, et al. Randomized controlled trial of selective bowel decontamination for prevention of infections following liver transplantation. Clin Infect Dis. 1996;22:997-1003. (Pubitemid 26260602)